An international drug trial that could change the way high blood pressure is controlled has shown a combination of two common hypertension medications can bring the often-lethal condition under control, even in the most dangerous cases.
In the trial, which was stopped early because the results were so positive, researchers found patients who took a so-called ACE-inhibitor and CCB combination pill suffered 20 per cent fewer major cardiac events, including death from heart attack and stroke.
The interim results, which doctors say should “shake the foundations” of current treatment, were presented yesterday at a meeting of the American College of Cardiology in Chicago.